TRACK-HD is a multi-centre, multi-national prospective,
observational biomarker study of premanifest and early stage HD with no experimental
treatment. Objectives- determine what combination of measures is the most sensitive
for detecting change over the natural course of premanifest and early HD
- to validate these as potential outcome measures for use in future therapeutic trials
Design- focused on intensive battery of novel assessments
- extensive annual assessments
- dynamic and fluid protocol
- robust evidence-based measures
| | Overview- Recruitment began late 2007
- Study visits began January 2008
- Baseline visits (n=366) completed July 2008
- Database lock August 2008
- Analysis of baseline data completed
- Preliminary results published in major neurology journal
- 12-month Follow-up visits began January 2009
- 12-month Follow-up visits (n=353) completed September 2009
- Analysis of Year 1 follow up data underway
|